Transcatheter Aortic Valve Replacement Market Report 2025 – Insights for Decision Makers and Market Strategists

 Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What is the forecasted revenue size of the transcatheter aortic valve replacement industry by 2029?
The transcatheter aortic valve replacement market size has grown rapidly in recent years. It will grow from $5.19 billion in 2024 to $5.91 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to the rising prevalence of aortic regurgitation, rising prevalence of cardiovascular diseases, increasing patient preference for minimally invasive therapies, global expansion of TAVR procedures, favorable reimbursement policies

The transcatheter aortic valve replacement market size is expected to see rapid growth in the next few years. It will grow to $9.97 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to the increasing prevalence of aortic stenosis, growing adoption of minimally invasive procedures, expansion of indications for TAVR procedures, favorable reimbursement policies, and rising awareness of TAVR as a viable treatment avenue. Major trends in the forecast period include the continuous evolution of device technology, rising prevalence of cardiovascular diseases, global expansion of TAVR procedures, an aging demographic, and rising healthcare expenditure.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp

Which industry-specific innovations are acting as key drivers for the transcatheter aortic valve replacement market?
The increase in the prevalence of aortic stenosis is one of the driving factors for the transcatheter aortic valve replacement market going forward. Aortic stenosis is a medical condition that refers to the narrowing of the aortic valve in the heart. It can be treated with transcatheter aortic valve replacement (TAVR), a less invasive alternative to surgical aortic valve replacement (SAVR) that aids in restoring blood flow and reducing the signs and symptoms of aortic valve stenosis. For instance, in May 2024, according to a data published by the American Heart Association, a US-based nonprofit organization, over 12% of older Americans are affected by aortic stenosis, a condition frequently seen in individuals over 65. If left untreated, it can result in heart failure and potentially be fatal . Furthermore, in March 2023, according to the report published by the National Institute for Health and Care Excellence (NICE), a UK-based public organization, nearly 1.5% of people over 55 in the UK, or around 300,000, live with severe aortic stenosis, with just under 200,000 having symptomatic disease requiring treatment, contributing to over 380,000 people on cardiac waiting lists by March 2023. Therefore, the increase in the prevalence of aortic stenosis is driving the transcatheter aortic valve replacement market

Which segment currently leads the transcatheter aortic valve replacement market in terms of revenue share?
The transcatheter aortic valve replacement market covered in this report is segmented –

1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/transcatheter-aortic-valve-replacement-global-market-report

What are the key trends shaping the transcatheter aortic valve replacement market in the forecast period?
Product innovation is a key trend gaining traction in the transcatheter aortic valve replacement (TAVR) market. Companies operating in the transcatheter aortic valve replacement sector are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in May 2024, Edwards Lifesciences, a US-based medical technology company, launched the Sapien 3 Ultra Resilia valve in Europe, marking the only transcatheter aortic valve replacement (TAVR) system that features the company’s Resilia tissue technology. This innovative technology, designed to enhance the valve's longevity, uses bovine pericardial tissue treated with anti-calcification methods. By incorporating this calcium-blocking technology, the Resilia platform helps to mitigate structural valve deterioration, a leading cause of reintervention following valve replacement.

Who are the top competitors in the global transcatheter aortic valve replacement market?
Major companies operating in the transcatheter aortic valve replacement market include Abbott Laboratories Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc, Braile Biomedica, Peijia Medical Limited, Direct Flow Medical Inc., Transcatheter Technologies GmbH, Symetis SA, JenaValve Technology Inc., Micro Interventional Devices Inc., Xeltis BV, Tendyne Holdings Inc., MVRx Inc., Keystone Heart Ltd., Colibri Heart Valve LLC, HighLife SAS, Neovasc Inc., Aegis Surgical Limited, Foldax Inc., MValve Technologies Ltd., NaviGate Cardiac Structures Inc.

What regional dynamics are shaping the future of the global transcatheter aortic valve replacement market?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can Companies Use The Transcatheter Aortic Valve Replacement Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12031

Need Customized Data On Transcatheter Aortic Valve Replacement Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=12031&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company